Urinary Incontinence: Clinical Trials

9 trials for Urinary Incontinence, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting, 1 suspended, 1 terminated. 9 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 19Completed 4, Recruiting 1, Suspended 1, Terminated 1, Unknown 1, Withdrawn 1

Follow Urinary Incontinence: new trials by email Literature Review of Urinary Incontinence trials Research Report on Urinary Incontinence

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial Cystitis
Desert Harvest Aloe Vera Capsules, Placebo Capsules - Interstitial Cystitis, Chronic Interstitial Cystitis
Early Phase 1RecruitingWake Forest University Health Sciences302025-02-182026-07-28
Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls
Pelvic Floor Muscle Training, Mirabegron, Trospium Chloride - Urinary Bladder, Overactive, Urinary Incontinence
Early Phase 1CompletedThe University of Texas Medical Branch, Galveston482023-09-282026-06-22
Vaginal Estradiol Use in Pessary Care
Estradiol vaginal cream - Pelvic Organ Prolapse, Urinary Incontinence
Early Phase 1TerminatedUniversity of South Florida112022-12-292023-05-11
Feasibility of BOTOX Injection on Improving Female Stress Urinary Incontinence
onabotulinumtoxin A - Stress Urinary Incontinence
Early Phase 1SuspendedNorthwell Health202022-02-142026-01-26
Repetitive Transcranial Magnetic Stimulation in Women With Overactive Bladder With Urgency Incontinence
Repetitive Transcranial Magnetic Stimulation - Overactive Bladder, Urge Incontinence
Early Phase 1UnknownUniversity of Southern California102021-10-282021-11-17
Transvaginal Botulinum Toxin A Chemodenervation for Overactive Bladder
Transvaginal botulinum toxin A (BTA) injection - Overactive Bladder, Bladder, Overactive
Early Phase 1CompletedStanford University152019-06-202022-07-19
IVES for Treatment of UUI and OAB
EMED detruset(TM) intravesical electrical stimulation - Urinary Bladder, Overactive, Urinary Incontinence, Urge
Early Phase 1CompletedLoma Linda University172014-12-012017-01-04
Neuropathic Investigation and Anticholinergic Treatment of Bladder Dysfunction in Diabetes and Stroke Patients
Fesoterodine Oral Product - Urinary Incontinence, Bladder Dysfunction
Early Phase 1WithdrawnSaint Thomas Health2009-09-152018-09-11
Dynamic MRI of the Behaviour of Female Pelvic Floor
movement of midurethra, bladder neck, cervix and rectum - Stress Urinary Incontinence, Genital Prolapse
Early Phase 1CompletedKuopio University Hospital742002-01-012008-09-05

Narrower conditions

Urinary Bladder, Overactive (4)  ·  Urinary Incontinence, Urge (3)  ·  Urinary Incontinence, Stress (2)  ·  Cystitis, Interstitial (1)  ·  Nocturia (1)  ·  Pelvic Organ Prolapse (1)  ·  Stroke (1)

Broader conditions

Female Urogenital Diseases (9)  ·  Female Urogenital Diseases and Pregnancy Complications (9)  ·  Lower Urinary Tract Symptoms (9)  ·  Male Urogenital Diseases (9)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  Signs and Symptoms (9)  ·  Urination Disorders (9)  ·  Urogenital Diseases (9)  ·  Urologic Diseases (9)  ·  Urological Manifestations (9)  ·  Urinary Bladder Diseases (5)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)

Interventions

Botulinum Toxins, Type A (1)  ·  Cellulose (1)  ·  Estradiol (1)  ·  Injections (1)  ·  Transcranial Magnetic Stimulation (1)  ·  fesoterodine (1)  ·  mirabegron (1)  ·  trospium chloride (1)

Sponsors

Kuopio University Hospital (1)  ·  Loma Linda University (1)  ·  Northwell Health (1)  ·  Saint Thomas Health (1)  ·  Stanford University (1)  ·  The University of Texas Medical Branch, Galveston (1)  ·  University of South Florida (1)  ·  University of Southern California (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (8)  ·  Finland (1)

Top investigators

Alexandra N Garcia, MD (1)  ·  Amy D. Dobberfuhl, M.D. (1)  ·  Barry K Jarnagin, MD (1)  ·  Bilal Chughtai, MD (1)  ·  Larissa Rodriguez, MD (1)  ·  Sam Siddighi, MD (1)  ·  Stephen Walker, PhD (1)  ·  Steve Fisher (1)

Results publications

PMID 34156506, PMID 35607890, PMID 38178267

NIH funding

R21AG081900 (1)